CIBC Asset Management Inc Has $1.30 Million Stock Holdings in Solventum Co. (NYSE:SOLV)

CIBC Asset Management Inc grew its holdings in Solventum Co. (NYSE:SOLV) by 2.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,673 shares of the company’s stock after purchasing an additional 382 shares during the quarter. CIBC Asset Management Inc’s holdings in Solventum were worth $1,300,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Blue Trust Inc. lifted its stake in shares of Solventum by 2.1% in the 4th quarter. Blue Trust Inc. now owns 7,872 shares of the company’s stock valued at $549,000 after purchasing an additional 161 shares during the period. MML Investors Services LLC raised its stake in Solventum by 3.2% during the 3rd quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock worth $373,000 after buying an additional 168 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its stake in Solventum by 4.2% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock worth $346,000 after buying an additional 200 shares during the period. Savant Capital LLC raised its stake in Solventum by 6.3% during the 4th quarter. Savant Capital LLC now owns 3,914 shares of the company’s stock worth $259,000 after buying an additional 233 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in Solventum by 2.0% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,677 shares of the company’s stock worth $904,000 after buying an additional 264 shares during the period.

Analyst Ratings Changes

A number of research analysts recently weighed in on SOLV shares. Morgan Stanley upped their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. Mizuho started coverage on Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price target on the stock. Finally, Piper Sandler upped their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Solventum has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Down 1.9 %

Shares of SOLV opened at $73.08 on Friday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The stock has a 50 day moving average price of $71.14 and a two-hundred day moving average price of $69.15. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.